Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: J Nucl Cardiol. 2018 Jun 19;27(3):1010–1021. doi: 10.1007/s12350-018-1326-4

Table 1.

Clinical Variables.

Type Variable
General Clinical Variables Patient Location (In-patient, Out-patient, Emergency Department)
Age, Gender
Height (cm), Weight (kg), Body Mass Index (kg/m2)
Clinical Indications for Test
Pre-Test Likelihood of Coronary Artery Disease
Family History of Coronary Artery Disease
Hypertension
Diabetes Mellitus
Dyslipidemia
Currently Smoking
Current Medications
Anginal Presenting Symptoms
Imaging Protocol
Quality of MPI Study
Visual Perfusion Assessment
Summed Stress Score, Summed Rest Score, Summed Difference Score
History of Heart Disease Past Myocardial Infarction
Past PCI/CABG
Past Transcatheter Aortic Valve Replacement
Past Cardiac Transplant
Past Other Open-Heart Surgery
Peripheral Artery Disease
Left Ventricular Hypertrophy
Conduction Disease
Stress variables Pharmacologic Stress Agent
Stress Test Type Agent
Exercise Protocol
Resting Heart Rate (bpm)
Peak Heart Rate at Stress (Pharmacologic or Exercise Stress) (bpm)
Resting Blood Pressure (BP): Systolic, Diastolic (mmHg)
Peak Blood Pressure at Stress: Systolic, Diastolic (mmHg)
% of Maximal Predicted Heart Rate
Exercise Duration (min)
Reason for Termination
ECG Response to Stress
Clinical Response to Stress
ECG ST Deviation (mm) Direction, and Slope
Invasive Coronary Angiography and Revascularization Invasive Coronary Angiography: Time Interval to MPI
Severity of Coronary Stenosis Per Coronary Artery Territory
Revascularization: Time Interval to MPI, Type (PCI or CABG), vessel
MACE Variables Type MACE (All-Cause Death, Myocardial Infarction, Unstable Angina, Revascularization), MACE Interval from MPI, Follow-up Interval.

ECG: Electrocardiogram; CABG: Coronary artery bypass grafting; PCI: Percutaneous coronary intervention, MACE: major adverse cardiac events.